Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: Here’s everything you need to know about Biogen’s Q4 report
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the fourth quarter of 2023.
Total revenue declined 6% year-over-year to $2.39 billion. For the full year of 2024, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen Inc. was $249.7 million or $1.71 per share in Q4, compared to $550.4 million or $3.79 per share in the prior-year period. Adjusted earnings declined 27% to $2.95 per share in the December quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Dollar Tree (DLTR): Key points of note from the Q3 2024 earnings report
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 2% on Wednesday after the company delivered better-than-expected earnings results for the third quarter of 2024. The discount retailer beat estimates
FL Earnings: Foot Locker Q3 2024 adj. profit rises; sales down 1%
Foot Locker, Inc. (NYSE: FL), a leading footwear and apparel retailer, reported an increase in adjusted profit for the third quarter of 2024 and a modest decrease in sales. Net sales
Infographic: How The Campbell’s Company (CPB) performed in Q1 2025
The Campbell's Company (NASDAQ: CPB) reported net sales of $2.8 billion for the first quarter of 2025, up 10% from the same period a year ago. Organic sales decreased 1%.
